The assessment of pulmonary drug absorption and deposition is becoming incr
easingly important in drug development. Absorption information can be used
to maximize pulmonary selectivity, to screen drug candidates and to help ev
aluate the bioequivalence of generic inhalation products. Several methods a
re available to investigate pulmonary drug absorption and deposition, rangi
ng from in vitro experiments to in vivo pharmacokinetic and pharmacodynamic
analyses. In combination, these methods can indicate the fate of an inhale
d drug.